The Department of Health and Human Services will invest up to $90 million over five years in a partnership with Rempex Pharmaceuticals to further develop an experimental drug against biothreat pathogens and drug-resistant
MoreProcessing....
The Department of Health and Human Services will invest up to $90 million over five years in a partnership with Rempex Pharmaceuticals to further develop an experimental drug against biothreat pathogens and drug-resistant
MoreLogin Here
To enjoy unlimited access to articles, interviews, and invaluable govcon content. You’ll also receive our daily briefing straight to your inbox.